| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activity | 3.38e-05 | 18 | 71 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | cyclase activity | 8.26e-05 | 24 | 71 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 9.37e-05 | 25 | 71 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 9.37e-05 | 25 | 71 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.24e-04 | 5 | 71 | 2 | GO:0008294 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 6.60e-06 | 11 | 72 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 1.67e-05 | 44 | 72 | 4 | GO:0007212 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 6.25e-05 | 286 | 72 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 6.87e-05 | 23 | 72 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 7.40e-05 | 64 | 72 | 4 | GO:1903351 | |
| GeneOntologyBiologicalProcess | response to dopamine | 8.35e-05 | 66 | 72 | 4 | GO:1903350 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 8.88e-05 | 25 | 72 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 9.39e-05 | 68 | 72 | 4 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 9.39e-05 | 68 | 72 | 4 | GO:0071870 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 1.24e-04 | 73 | 72 | 4 | GO:0071869 | |
| GeneOntologyBiologicalProcess | response to monoamine | 1.31e-04 | 74 | 72 | 4 | GO:0071867 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 2.33e-04 | 86 | 72 | 4 | GO:0007193 | |
| Domain | Adcy_conserved_dom | 1.04e-06 | 6 | 71 | 3 | IPR009398 | |
| Domain | DUF1053 | 1.04e-06 | 6 | 71 | 3 | PF06327 | |
| Domain | AC_N | 2.91e-06 | 8 | 71 | 3 | IPR032628 | |
| Domain | Adcy | 2.91e-06 | 8 | 71 | 3 | IPR030672 | |
| Domain | AC_N | 2.91e-06 | 8 | 71 | 3 | PF16214 | |
| Domain | EGF_2 | 7.26e-06 | 265 | 71 | 8 | PS01186 | |
| Domain | - | 8.46e-06 | 73 | 71 | 5 | 2.60.120.260 | |
| Domain | Growth_fac_rcpt_ | 2.82e-05 | 156 | 71 | 6 | IPR009030 | |
| Domain | Galactose-bd-like | 2.91e-05 | 94 | 71 | 5 | IPR008979 | |
| Domain | EGF_3 | 3.06e-05 | 235 | 71 | 7 | PS50026 | |
| Domain | EGF | 3.06e-05 | 235 | 71 | 7 | SM00181 | |
| Domain | A/G_cyclase_CS | 3.45e-05 | 17 | 71 | 3 | IPR018297 | |
| Domain | Nucleotide_cyclase | 4.12e-05 | 18 | 71 | 3 | IPR029787 | |
| Domain | - | 4.12e-05 | 18 | 71 | 3 | 3.30.70.1230 | |
| Domain | EGF-like_dom | 4.43e-05 | 249 | 71 | 7 | IPR000742 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.88e-05 | 19 | 71 | 3 | PS00452 | |
| Domain | Guanylate_cyc | 4.88e-05 | 19 | 71 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.88e-05 | 19 | 71 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.88e-05 | 19 | 71 | 3 | IPR001054 | |
| Domain | CYCc | 4.88e-05 | 19 | 71 | 3 | SM00044 | |
| Domain | EGF_1 | 5.15e-05 | 255 | 71 | 7 | PS00022 | |
| Domain | FA58C | 6.67e-05 | 21 | 71 | 3 | SM00231 | |
| Domain | FA58C_3 | 6.67e-05 | 21 | 71 | 3 | PS50022 | |
| Domain | FA58C_1 | 6.67e-05 | 21 | 71 | 3 | PS01285 | |
| Domain | FA58C_2 | 6.67e-05 | 21 | 71 | 3 | PS01286 | |
| Domain | F5_F8_type_C | 1.01e-04 | 24 | 71 | 3 | PF00754 | |
| Domain | FA58C | 1.01e-04 | 24 | 71 | 3 | IPR000421 | |
| Domain | FIBRINOGEN_C_1 | 2.41e-04 | 32 | 71 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.41e-04 | 32 | 71 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.41e-04 | 32 | 71 | 3 | PS51406 | |
| Domain | LAM_G_DOMAIN | 4.04e-04 | 38 | 71 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 4.70e-04 | 40 | 71 | 3 | PF02210 | |
| Domain | - | 4.70e-04 | 95 | 71 | 4 | 2.60.120.200 | |
| Domain | RFX_DNA_binding | 5.04e-04 | 9 | 71 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 5.04e-04 | 9 | 71 | 2 | IPR003150 | |
| Domain | RFX_DBD | 5.04e-04 | 9 | 71 | 2 | PS51526 | |
| Domain | LamG | 6.23e-04 | 44 | 71 | 3 | SM00282 | |
| Domain | Laminin_G | 1.40e-03 | 58 | 71 | 3 | IPR001791 | |
| Domain | G-alpha | 1.65e-03 | 16 | 71 | 2 | PF00503 | |
| Domain | GproteinA_insert | 1.65e-03 | 16 | 71 | 2 | IPR011025 | |
| Domain | - | 1.65e-03 | 16 | 71 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 1.65e-03 | 16 | 71 | 2 | SM00275 | |
| Domain | TSP_1 | 1.78e-03 | 63 | 71 | 3 | PF00090 | |
| Domain | Gprotein_alpha_su | 1.87e-03 | 17 | 71 | 2 | IPR001019 | |
| Domain | TSP1 | 1.94e-03 | 65 | 71 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.94e-03 | 65 | 71 | 3 | IPR000884 | |
| Domain | TSP1 | 1.94e-03 | 65 | 71 | 3 | PS50092 | |
| Domain | PLAC | 2.34e-03 | 19 | 71 | 2 | PS50900 | |
| Domain | PLAC | 2.34e-03 | 19 | 71 | 2 | IPR010909 | |
| Domain | EGF-like_CS | 3.15e-03 | 261 | 71 | 5 | IPR013032 | |
| Domain | Ephrin_rec_like | 4.04e-03 | 25 | 71 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 4.04e-03 | 25 | 71 | 2 | IPR011641 | |
| Domain | FBG | 5.41e-03 | 29 | 71 | 2 | SM00186 | |
| Domain | - | 5.79e-03 | 30 | 71 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 5.79e-03 | 30 | 71 | 2 | IPR014716 | |
| Domain | EGF_Ca-bd_CS | 6.01e-03 | 97 | 71 | 3 | IPR018097 | |
| Domain | EGF_CA | 6.36e-03 | 99 | 71 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.54e-03 | 100 | 71 | 3 | PS00010 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.71e-07 | 15 | 49 | 4 | M47794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.71e-07 | 15 | 49 | 4 | M47504 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.27e-07 | 16 | 49 | 4 | M39849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.27e-07 | 16 | 49 | 4 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.27e-07 | 16 | 49 | 4 | M47650 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 2.97e-07 | 17 | 49 | 4 | M26995 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.30e-06 | 24 | 49 | 4 | M47520 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.13e-06 | 27 | 49 | 4 | M47518 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 2.48e-06 | 28 | 49 | 4 | M47647 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.72e-06 | 115 | 49 | 6 | M9387 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.87e-06 | 29 | 49 | 4 | M47515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 2.87e-06 | 29 | 49 | 4 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.78e-06 | 31 | 49 | 4 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 4.31e-06 | 32 | 49 | 4 | M47506 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 4.66e-06 | 10 | 49 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 4.66e-06 | 10 | 49 | 3 | MM14668 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 4.89e-06 | 33 | 49 | 4 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 6.23e-06 | 35 | 49 | 4 | M47969 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 9.69e-06 | 39 | 49 | 4 | MM14496 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.40e-05 | 14 | 49 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.40e-05 | 14 | 49 | 3 | M750 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.44e-05 | 43 | 49 | 4 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.44e-05 | 43 | 49 | 4 | M933 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.45e-05 | 90 | 49 | 5 | MM15882 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.45e-05 | 90 | 49 | 5 | M835 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.53e-05 | 91 | 49 | 5 | M39426 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.73e-05 | 45 | 49 | 4 | M45008 | |
| Pathway | PID_LPA4_PATHWAY | 1.74e-05 | 15 | 49 | 3 | M56 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.89e-05 | 46 | 49 | 4 | M39828 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.14e-05 | 16 | 49 | 3 | MM14492 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.24e-05 | 48 | 49 | 4 | M10775 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.54e-05 | 101 | 49 | 5 | M1979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M47544 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 3.08e-05 | 52 | 49 | 4 | M920 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.51e-05 | 108 | 49 | 5 | M17034 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.59e-05 | 54 | 49 | 4 | M26911 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.32e-05 | 20 | 49 | 3 | M759 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.81e-05 | 61 | 49 | 4 | MM15071 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 6.60e-05 | 63 | 49 | 4 | M8 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 7.46e-05 | 65 | 49 | 4 | M15 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 9.70e-05 | 26 | 49 | 3 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 9.70e-05 | 26 | 49 | 3 | MM14495 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.05e-04 | 71 | 49 | 4 | MM14491 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.09e-04 | 27 | 49 | 3 | M47519 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.11e-04 | 72 | 49 | 4 | MM14631 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.50e-04 | 30 | 49 | 3 | M42578 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.52e-04 | 147 | 49 | 5 | MM15854 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.52e-04 | 78 | 49 | 4 | M1921 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.72e-04 | 151 | 49 | 5 | M39329 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.82e-04 | 32 | 49 | 3 | MM14854 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.00e-04 | 33 | 49 | 3 | MM15058 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.16e-04 | 250 | 49 | 6 | M27554 | |
| Pathway | KEGG_GAP_JUNCTION | 2.64e-04 | 90 | 49 | 4 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.64e-04 | 90 | 49 | 4 | M6467 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.82e-04 | 37 | 49 | 3 | M27134 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.82e-04 | 37 | 49 | 3 | M749 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.27e-04 | 8 | 49 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.30e-04 | 39 | 49 | 3 | MM14601 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.83e-04 | 41 | 49 | 3 | M512 | |
| Pathway | KEGG_MELANOGENESIS | 4.11e-04 | 101 | 49 | 4 | M7761 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.12e-04 | 42 | 49 | 3 | M791 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 4.42e-04 | 43 | 49 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 4.73e-04 | 44 | 49 | 3 | MM15709 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.73e-04 | 44 | 49 | 3 | M26969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M47648 | |
| Pathway | WP_THERMOGENESIS | 5.29e-04 | 108 | 49 | 4 | M39746 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 6.28e-04 | 113 | 49 | 4 | M27471 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 7.27e-04 | 314 | 49 | 6 | M600 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 7.74e-04 | 52 | 49 | 3 | M5785 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 9.12e-04 | 55 | 49 | 3 | M39763 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.18e-03 | 60 | 49 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 1.18e-03 | 60 | 49 | 3 | MM15708 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.19e-03 | 134 | 49 | 4 | M29840 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS | 1.21e-03 | 15 | 49 | 2 | M39498 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47551 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.51e-03 | 143 | 49 | 4 | M27275 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 1.56e-03 | 17 | 49 | 2 | MM14580 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 1.56e-03 | 17 | 49 | 2 | M626 | |
| Pathway | WP_TRANSCRIPTIONAL_ACTIVATION_BY_NFE2L2_IN_RESPONSE_TO_PHYTOCHEMICALS | 1.56e-03 | 17 | 49 | 2 | MM15891 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.69e-03 | 68 | 49 | 3 | M27303 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.75e-03 | 18 | 49 | 2 | MM15024 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.80e-03 | 150 | 49 | 4 | M27440 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.95e-03 | 19 | 49 | 2 | M27310 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.98e-03 | 154 | 49 | 4 | MM15974 | |
| Pathway | WP_AXON_GUIDANCE | 1.99e-03 | 72 | 49 | 3 | M48335 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.08e-03 | 156 | 49 | 4 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.12e-03 | 157 | 49 | 4 | M4904 | |
| Pathway | KEGG_PURINE_METABOLISM | 2.23e-03 | 159 | 49 | 4 | M14314 | |
| Pathway | WP_ESTROGEN_SIGNALING | 2.41e-03 | 77 | 49 | 3 | MM15934 | |
| Pathway | KEGG_GLYCEROPHOSPHOLIPID_METABOLISM | 2.41e-03 | 77 | 49 | 3 | M9131 | |
| Pathway | WP_NRF2ARE_REGULATION | 2.86e-03 | 23 | 49 | 2 | M39761 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.86e-03 | 23 | 49 | 2 | MM15033 | |
| Pathway | WP_PURINE_METABOLISM | 2.90e-03 | 171 | 49 | 4 | MM15909 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.19e-03 | 289 | 49 | 5 | MM15057 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 3.19e-03 | 85 | 49 | 3 | M3578 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.34e-03 | 178 | 49 | 4 | M2890 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 4.22e-03 | 28 | 49 | 2 | M10679 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 4.37e-03 | 95 | 49 | 3 | M29842 | |
| Pathway | WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122 | 5.16e-03 | 31 | 49 | 2 | M42531 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.52e-03 | 205 | 49 | 4 | M752 | |
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 8.25e-09 | 12 | 72 | 4 | 9611134 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 21228062 | ||
| Pubmed | Function of latent TGFβ binding protein 4 and fibulin 5 in elastogenesis and lung development. | 8.48e-08 | 5 | 72 | 3 | 24962333 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 1.69e-07 | 6 | 72 | 3 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 1.69e-07 | 6 | 72 | 3 | 11549699 | |
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 12613887 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 7.08e-07 | 9 | 72 | 3 | 9417641 | |
| Pubmed | 7.08e-07 | 9 | 72 | 3 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 7.08e-07 | 9 | 72 | 3 | 17229090 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.01e-06 | 10 | 72 | 3 | 8663304 | |
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.01e-06 | 10 | 72 | 3 | 11884542 | |
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 10089566 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 10808179 | ||
| Pubmed | Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits. | 1.85e-06 | 12 | 72 | 3 | 17110384 | |
| Pubmed | 1.85e-06 | 12 | 72 | 3 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 3.05e-06 | 14 | 72 | 3 | 14993377 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 4.23e-06 | 2 | 72 | 2 | 19734365 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31009605 | ||
| Pubmed | Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. | 4.23e-06 | 2 | 72 | 2 | 23382201 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17068292 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 25893671 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31162142 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20431059 | ||
| Pubmed | Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands. | 4.23e-06 | 2 | 72 | 2 | 29327289 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 9228084 | ||
| Pubmed | Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. | 4.23e-06 | 2 | 72 | 2 | 21282557 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 10481931 | ||
| Pubmed | 4.67e-06 | 16 | 72 | 3 | 17567809 | ||
| Pubmed | Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. | 1.27e-05 | 3 | 72 | 2 | 9268375 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31173603 | ||
| Pubmed | Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. | 1.27e-05 | 3 | 72 | 2 | 16973443 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 27826057 | ||
| Pubmed | Chromosomal mapping of human adenylyl cyclase genes type III, type V and type VI. | 1.27e-05 | 3 | 72 | 2 | 8034296 | |
| Pubmed | Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. | 1.27e-05 | 3 | 72 | 2 | 22829427 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 25257729 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 25713297 | ||
| Pubmed | Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells. | 1.27e-05 | 3 | 72 | 2 | 19889965 | |
| Pubmed | Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor. | 1.27e-05 | 3 | 72 | 2 | 17593019 | |
| Pubmed | ZNF148 ARID2 ASPM CLSTN2 TAF5 LTBP4 PHF5A ADCY6 UNC5D NKRF ZNF574 | 1.78e-05 | 1116 | 72 | 11 | 31753913 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 21184583 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 17081159 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 25049074 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 18755267 | ||
| Pubmed | 3.67e-05 | 31 | 72 | 3 | 12626323 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 19897194 | ||
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 4.21e-05 | 5 | 72 | 2 | 7959689 | |
| Pubmed | Satb1 Regulates Contactin 5 to Pattern Dendrites of a Mammalian Retinal Ganglion Cell. | 4.21e-05 | 5 | 72 | 2 | 28781169 | |
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 19349279 | ||
| Pubmed | Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. | 6.31e-05 | 6 | 72 | 2 | 17557924 | |
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 24944202 | ||
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 12748287 | ||
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 10930463 | ||
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 17310244 | ||
| Pubmed | 1.46e-04 | 49 | 72 | 3 | 24378760 | ||
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 12297500 | ||
| Pubmed | 1.88e-04 | 10 | 72 | 2 | 8588930 | ||
| Pubmed | 1.95e-04 | 985 | 72 | 9 | 12975309 | ||
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 11299302 | ||
| Pubmed | 2.78e-04 | 814 | 72 | 8 | 23251661 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 36963288 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 17804598 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 7937899 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 4.36e-04 | 15 | 72 | 2 | 2165385 | |
| Pubmed | Structure of the human activated spliceosome in three conformational states. | 4.98e-04 | 16 | 72 | 2 | 29360106 | |
| Pubmed | The Genetic Basis of Baculum Size and Shape Variation in Mice. | 4.98e-04 | 16 | 72 | 2 | 26935419 | |
| Pubmed | 5.58e-04 | 493 | 72 | 6 | 15368895 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 6.14e-04 | 186 | 72 | 4 | 33637726 | |
| Pubmed | 6.33e-04 | 18 | 72 | 2 | 30410068 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 6.47e-04 | 925 | 72 | 8 | 28986522 | |
| Pubmed | 7.04e-04 | 193 | 72 | 4 | 22589738 | ||
| Pubmed | 7.84e-04 | 20 | 72 | 2 | 32702291 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 8.18e-04 | 1201 | 72 | 9 | 35696571 | |
| Pubmed | 8.88e-04 | 1215 | 72 | 9 | 15146197 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 9.07e-04 | 91 | 72 | 3 | 28558017 | |
| Pubmed | 9.50e-04 | 22 | 72 | 2 | 22837474 | ||
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 1.04e-03 | 23 | 72 | 2 | 14715245 | |
| Pubmed | 1.12e-03 | 98 | 72 | 3 | 19554387 | ||
| Pubmed | 1.13e-03 | 24 | 72 | 2 | 23827503 | ||
| Pubmed | The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. | 1.23e-03 | 25 | 72 | 2 | 19240132 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.38e-03 | 588 | 72 | 6 | 38580884 | |
| Pubmed | Molecular signatures and cellular diversity during mouse habenula development. | 1.54e-03 | 28 | 72 | 2 | 35793630 | |
| Pubmed | 1.54e-03 | 28 | 72 | 2 | 8858601 | ||
| Pubmed | 1.64e-03 | 1327 | 72 | 9 | 32694731 | ||
| Pubmed | 1.64e-03 | 608 | 72 | 6 | 16713569 | ||
| Pubmed | 1.75e-03 | 417 | 72 | 5 | 36537216 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.78e-03 | 248 | 72 | 4 | 24006456 | |
| Pubmed | 1.89e-03 | 31 | 72 | 2 | 27798109 | ||
| Pubmed | 2.00e-03 | 430 | 72 | 5 | 16303743 | ||
| Pubmed | 2.01e-03 | 120 | 72 | 3 | 21697133 | ||
| Cytoband | 10q22.2 | 1.91e-03 | 41 | 72 | 2 | 10q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q21 | 2.08e-03 | 160 | 72 | 3 | chr3q21 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.65e-06 | 10 | 52 | 3 | 53 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-07 | 179 | 72 | 6 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.92e-07 | 187 | 72 | 6 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-07 | 189 | 72 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-07 | 190 | 72 | 6 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.50e-07 | 190 | 72 | 6 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-07 | 191 | 72 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 72 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.37e-06 | 166 | 72 | 5 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.37e-06 | 166 | 72 | 5 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-06 | 169 | 72 | 5 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-06 | 169 | 72 | 5 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 181 | 72 | 5 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 181 | 72 | 5 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 183 | 72 | 5 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 183 | 72 | 5 | c7e94fe3e7669db9304b249979fef7a69c30a143 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 183 | 72 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 183 | 72 | 5 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 184 | 72 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 184 | 72 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 184 | 72 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 184 | 72 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 185 | 72 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 186 | 72 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 186 | 72 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-05 | 186 | 72 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 187 | 72 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 187 | 72 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 188 | 72 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 188 | 72 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 188 | 72 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 189 | 72 | 5 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 189 | 72 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-05 | 190 | 72 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 191 | 72 | 5 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 191 | 72 | 5 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 72 | 5 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 192 | 72 | 5 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.57e-05 | 194 | 72 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | EC-Arteriolar_ECs|World / Lineage and Cell class | 1.57e-05 | 194 | 72 | 5 | 38f0c52de252101d4bc8633af80002061635e487 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 194 | 72 | 5 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | normal_Lung-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.57e-05 | 194 | 72 | 5 | d21461682fa755f588afe073abb6a777f339c4cc | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.61e-05 | 195 | 72 | 5 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Trm_Th1/Th17|Liver / Manually curated celltypes from each tissue | 1.61e-05 | 195 | 72 | 5 | 480cc62ee1e5b1aaf6b62be6e5afd7a81236a1b0 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 196 | 72 | 5 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.69e-05 | 197 | 72 | 5 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 198 | 72 | 5 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.73e-05 | 198 | 72 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.77e-05 | 199 | 72 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 199 | 72 | 5 | c4a1e0cf3be867e7cebbd8bd3668bc2df391671b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.81e-05 | 200 | 72 | 5 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.03e-05 | 118 | 72 | 4 | d7dcffc0476a6e471debd83904a6569c6f27a594 | |
| ToppCell | Control-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.30e-05 | 120 | 72 | 4 | 695dab6b01ad2c33cdcaf92bb9996ff2899ef77e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.41e-05 | 138 | 72 | 4 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.63e-05 | 139 | 72 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.98e-05 | 145 | 72 | 4 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.22e-05 | 146 | 72 | 4 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.47e-05 | 147 | 72 | 4 | 5e6dd2ddc67b3722f6528e7277cbc7f296098687 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.98e-05 | 149 | 72 | 4 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 150 | 72 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 158 | 72 | 4 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 160 | 72 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 160 | 72 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.41e-04 | 163 | 72 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-04 | 164 | 72 | 4 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 165 | 72 | 4 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 167 | 72 | 4 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 167 | 72 | 4 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.58e-04 | 168 | 72 | 4 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 169 | 72 | 4 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 171 | 72 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.73e-04 | 172 | 72 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 173 | 72 | 4 | 70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 173 | 72 | 4 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-04 | 173 | 72 | 4 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 175 | 72 | 4 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 175 | 72 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 175 | 72 | 4 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 175 | 72 | 4 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 175 | 72 | 4 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.89e-04 | 176 | 72 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-04 | 177 | 72 | 4 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 177 | 72 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 177 | 72 | 4 | 201b0a8e6402a18aff0bb7c14f2bdd34fdf0db32 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 177 | 72 | 4 | 2a63288d09efd217b277aeecf957811a095f56e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 177 | 72 | 4 | 56fe389ffab73e3bc64f837b152d5907e3517a91 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 177 | 72 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 178 | 72 | 4 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 178 | 72 | 4 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 178 | 72 | 4 | 60263c0bb9de3a57ba2ba543262a2ace0066fd85 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-04 | 178 | 72 | 4 | c90e9048fc786ba8559972ae25c25ecab4bc1b7c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-04 | 178 | 72 | 4 | 9e426ce23a4a33b91d139ad85685cf8483bcd01a | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 178 | 72 | 4 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| Drug | procaterol | 4.23e-07 | 48 | 72 | 5 | CID000004916 | |
| Drug | 6-fluoronorepinephrine | 5.28e-07 | 21 | 72 | 4 | CID000001862 | |
| Drug | CGP 20712A | 5.76e-07 | 51 | 72 | 5 | CID000002685 | |
| Drug | AC1L1EKQ | 6.36e-07 | 52 | 72 | 5 | CID000002834 | |
| Drug | beta-CNA | 7.78e-07 | 23 | 72 | 4 | CID005486190 | |
| Drug | 8-isoprostaglandin E1 | 1.27e-06 | 251 | 72 | 8 | CID000000214 | |
| Drug | iohexol | 1.42e-06 | 61 | 72 | 5 | CID000003730 | |
| Drug | AC1L1EV8 | 1.68e-06 | 8 | 72 | 3 | CID000002964 | |
| Drug | butoxamine | 1.78e-06 | 28 | 72 | 4 | CID000018026 | |
| Drug | prenalterol | 1.78e-06 | 28 | 72 | 4 | CID000042396 | |
| Drug | alprenolol | 1.81e-06 | 64 | 72 | 5 | CID000002119 | |
| Drug | tolazoline | 2.06e-06 | 29 | 72 | 4 | CID000005504 | |
| Drug | dihydroalprenolol | 2.37e-06 | 30 | 72 | 4 | CID000043216 | |
| Drug | AC1N2DGT | 2.37e-06 | 30 | 72 | 4 | CID004045015 | |
| Drug | 14,15-dihydroforskolin | 2.51e-06 | 9 | 72 | 3 | CID000194193 | |
| Drug | Gi-2 | 2.79e-06 | 195 | 72 | 7 | CID011957432 | |
| Drug | fenoldopam | 2.83e-06 | 70 | 72 | 5 | CID000003340 | |
| Drug | dopexamine | 3.09e-06 | 32 | 72 | 4 | CID000055483 | |
| Drug | i-Pr | 3.49e-06 | 73 | 72 | 5 | CID000448400 | |
| Drug | iodocyanopindolol | 3.51e-06 | 33 | 72 | 4 | CID000068618 | |
| Drug | 2',5'-dd3'-FSBA | 3.58e-06 | 10 | 72 | 3 | CID003081206 | |
| Drug | NC-5Z | 3.58e-06 | 10 | 72 | 3 | CID003035914 | |
| Drug | ketanserin | 3.70e-06 | 131 | 72 | 6 | CID000003822 | |
| Drug | Ts-I | 3.99e-06 | 75 | 72 | 5 | CID000445278 | |
| Drug | methiothepin | 4.55e-06 | 77 | 72 | 5 | CID000004106 | |
| Drug | AC1NY9KD | 4.91e-06 | 11 | 72 | 3 | CID005771741 | |
| Drug | AC1L40QM | 4.91e-06 | 11 | 72 | 3 | CID000099213 | |
| Drug | B-Mlvp | 4.91e-06 | 11 | 72 | 3 | CID000195648 | |
| Drug | practolol | 5.61e-06 | 37 | 72 | 4 | CID000004883 | |
| Drug | GI-3 | 7.19e-06 | 147 | 72 | 6 | CID011957433 | |
| Drug | mianserin | 8.30e-06 | 87 | 72 | 5 | CID000004184 | |
| Drug | FCE 23884 | 8.48e-06 | 13 | 72 | 3 | CID000065898 | |
| Drug | 2-thiothiazolidine-4-carboxylic acid | 8.48e-06 | 13 | 72 | 3 | CID003034757 | |
| Drug | AC1L1BJN | 8.48e-06 | 13 | 72 | 3 | CID000001467 | |
| Drug | nantradol hydrochloride | 8.48e-06 | 13 | 72 | 3 | CID000047652 | |
| Drug | sclareol glycol | 8.48e-06 | 13 | 72 | 3 | CID000091915 | |
| Drug | DAR-0100A | 8.52e-06 | 41 | 72 | 4 | CID000060759 | |
| Drug | BRL 37344 | 9.39e-06 | 42 | 72 | 4 | CID000002436 | |
| Drug | CGP 12177 | 9.39e-06 | 42 | 72 | 4 | CID000002687 | |
| Drug | carvedilol | 1.21e-05 | 161 | 72 | 6 | CID000002585 | |
| Drug | GDP-b-S | 1.25e-05 | 162 | 72 | 6 | CID000643998 | |
| Drug | SKF 75670 | 1.34e-05 | 15 | 72 | 3 | CID000173870 | |
| Drug | BMY 42393 | 1.34e-05 | 15 | 72 | 3 | CID000131961 | |
| Drug | AC1L2AAS | 1.34e-05 | 15 | 72 | 3 | CID000068714 | |
| Drug | levo-dromoran tartrate | 1.48e-05 | 98 | 72 | 5 | CID000003918 | |
| Drug | betaxolol | 1.61e-05 | 48 | 72 | 4 | CID000002369 | |
| Drug | Neomigran | 1.61e-05 | 48 | 72 | 4 | CID000003066 | |
| Drug | chelerythrine | 1.69e-05 | 357 | 72 | 8 | CID000002703 | |
| Drug | dihydroergocryptine | 1.75e-05 | 49 | 72 | 4 | CID000114948 | |
| Drug | PNU-107859 | 1.88e-05 | 174 | 72 | 6 | CID004369084 | |
| Drug | Gastrin tetrapeptide | 1.90e-05 | 50 | 72 | 4 | CID000005415 | |
| Drug | U754 | 2.00e-05 | 17 | 72 | 3 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 2.00e-05 | 17 | 72 | 3 | CID000084008 | |
| Drug | San 21009 | 2.00e-05 | 17 | 72 | 3 | CID000152662 | |
| Drug | racemic timolol | 2.05e-05 | 51 | 72 | 4 | CID000005478 | |
| Drug | Ro 41-9067 | 2.83e-05 | 19 | 72 | 3 | CID000125800 | |
| Drug | AC1L3XQA | 2.83e-05 | 19 | 72 | 3 | CID000124009 | |
| Drug | SK&F 82958 | 2.83e-05 | 19 | 72 | 3 | ctd:C071262 | |
| Drug | AC1MUNZL | 2.98e-05 | 56 | 72 | 4 | CID003643892 | |
| Drug | fenoterol | 2.98e-05 | 56 | 72 | 4 | CID000003343 | |
| Drug | ICI 118551 | 3.20e-05 | 57 | 72 | 4 | CID000003682 | |
| Drug | cyanopindolol | 3.20e-05 | 57 | 72 | 4 | CID000155346 | |
| Drug | Dvdavp | 3.33e-05 | 20 | 72 | 3 | CID006441676 | |
| Drug | YM435 | 3.33e-05 | 20 | 72 | 3 | CID000132119 | |
| Drug | NSC-4928 | 3.43e-05 | 58 | 72 | 4 | CID000221086 | |
| Drug | trequinsin | 3.43e-05 | 58 | 72 | 4 | CID000005537 | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.57e-05 | 195 | 72 | 6 | 4781_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 6611_DN | |
| Drug | reproterol | 3.87e-05 | 21 | 72 | 3 | CID000025654 | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 4546_DN | |
| Drug | ipsapirone | 4.19e-05 | 61 | 72 | 4 | CID000056971 | |
| Drug | GSK835726 | 4.47e-05 | 22 | 72 | 3 | CID005311268 | |
| Drug | CAS 66104-23-2 | 4.76e-05 | 63 | 72 | 4 | CID000004745 | |
| Drug | pindolol | 4.76e-05 | 63 | 72 | 4 | CID000004828 | |
| Drug | Scpb | 5.13e-05 | 23 | 72 | 3 | CID000123843 | |
| Drug | S-(-)-Lisuride | 5.38e-05 | 65 | 72 | 4 | CID000003938 | |
| Drug | AC1L1TJF | 5.71e-05 | 66 | 72 | 4 | CID000003377 | |
| Drug | NAIN | 5.85e-05 | 24 | 72 | 3 | CID000195228 | |
| Drug | TL-99 | 5.85e-05 | 24 | 72 | 3 | CID000122132 | |
| Drug | DEPX | 5.85e-05 | 24 | 72 | 3 | CID000001328 | |
| Drug | trimetoquinol | 5.85e-05 | 24 | 72 | 3 | CID000005581 | |
| Drug | AC1L8VEV | 5.85e-05 | 24 | 72 | 3 | CID000433433 | |
| Drug | Methoxamine | 5.89e-05 | 4 | 72 | 2 | ctd:D008729 | |
| Drug | GI-1 | 6.45e-05 | 133 | 72 | 5 | CID011957431 | |
| Drug | AC1L9NB5 | 6.63e-05 | 25 | 72 | 3 | CID000449609 | |
| Drug | PD 81,723 | 6.63e-05 | 25 | 72 | 3 | CID000122028 | |
| Drug | N-n-propylnorapomorphine | 6.63e-05 | 25 | 72 | 3 | CID000030137 | |
| Drug | tiotidine | 6.63e-05 | 25 | 72 | 3 | CID000050287 | |
| Drug | octimibate | 6.63e-05 | 25 | 72 | 3 | CID000065676 | |
| Drug | manganese-ATP | 6.63e-05 | 25 | 72 | 3 | CID000124341 | |
| Drug | iloprost | 6.68e-05 | 134 | 72 | 5 | CID005311181 | |
| Drug | SQ22536 | 6.92e-05 | 135 | 72 | 5 | CID000005270 | |
| Drug | 7B-forskolin | 7.48e-05 | 26 | 72 | 3 | CID000130638 | |
| Drug | metaproterenol | 7.48e-05 | 26 | 72 | 3 | CID000004086 | |
| Drug | 4-isopropylaniline | 7.61e-05 | 71 | 72 | 4 | CID000007464 | |
| Drug | synthetic pyrethrins | 7.61e-05 | 71 | 72 | 4 | CID000002982 | |
| Drug | RU 24926 | 8.40e-05 | 27 | 72 | 3 | CID000122203 | |
| Drug | SM-10906 | 8.40e-05 | 27 | 72 | 3 | CID006442261 | |
| Drug | 1,3-dipropylxanthine | 8.95e-05 | 74 | 72 | 4 | CID000169317 | |
| Drug | AC1NPJ0Q | 8.95e-05 | 74 | 72 | 4 | CID005159167 | |
| Disease | cutis laxa (implicated_via_orthology) | 1.66e-05 | 3 | 70 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | event-related brain oscillation | 3.32e-05 | 4 | 70 | 2 | EFO_0004358 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 5.52e-05 | 5 | 70 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | visceral adipose tissue measurement, body mass index | 5.57e-05 | 87 | 70 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | Cutis Laxa | 8.27e-05 | 6 | 70 | 2 | C0010495 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.54e-04 | 8 | 70 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.07e-04 | 122 | 70 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | complement factor H-related protein 1 measurement | 3.24e-04 | 56 | 70 | 3 | EFO_0600054 | |
| Disease | waist-hip ratio | EPHB2 NEDD9 PCSK5 DPP4 KCNT2 ADAMTS2 WDR11 TEX29 ABLIM3 ADCY5 | 6.07e-04 | 1226 | 70 | 10 | EFO_0004343 |
| Disease | body weight | 7.54e-04 | 1261 | 70 | 10 | EFO_0004338 | |
| Disease | Lung diseases | 8.56e-04 | 78 | 70 | 3 | C0024115 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.03e-03 | 20 | 70 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 1.03e-03 | 20 | 70 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | Attention Deficit Disorder | 1.24e-03 | 22 | 70 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.24e-03 | 22 | 70 | 2 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 1.48e-03 | 24 | 70 | 2 | C1263846 | |
| Disease | pallidum volume change measurement, age at assessment | 1.61e-03 | 25 | 70 | 2 | EFO_0008007, EFO_0021494 | |
| Disease | blood cobalt measurement | 1.80e-03 | 101 | 70 | 3 | EFO_0007577 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.87e-03 | 27 | 70 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | stimulant use measurement | 2.02e-03 | 28 | 70 | 2 | EFO_0600076 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YNCEDERCYLDLARL | 446 | Q5NDL2 | |
| TQDYQQLYGTRCDSC | 71 | O94929 | |
| CLDENNYDRERCSTY | 26 | Q9BUK0 | |
| ACRNFIQLCLEAYYD | 36 | Q6UX04 | |
| SAQDRQLLCFYYDQC | 701 | Q14511 | |
| RNDELYYQSCECVAV | 966 | O43306 | |
| QCVVDIYVNYDCDLN | 511 | Q9Y6D5 | |
| ICEYVDQDSYREIIC | 391 | Q68CP9 | |
| IDSQYYCNCDADRNE | 731 | Q9C0A0 | |
| NEDLYHQSYECVCVL | 861 | Q8NFM4 | |
| ECQYELTDRLAFYLC | 221 | Q9Y2X7 | |
| YLTLVRCAQDCEDYF | 236 | P27216 | |
| RCAQDCEDYFAERLY | 241 | P27216 | |
| ERRNDELYYQSCECV | 1056 | O95622 | |
| YDYTCLNLSEDHVCT | 256 | Q01459 | |
| EDCSPQYSQICNYEI | 186 | Q9H4D0 | |
| CCYRSKTQYEAVQSE | 2776 | Q8IZT6 | |
| CSQQELSRYLHSYDC | 451 | O95450 | |
| NCCTDSNLNGVYYRL | 296 | O43827 | |
| RYASLYFCCAIENQD | 61 | Q96PC3 | |
| YLDSQRAACRCHYEE | 171 | Q9BZM1 | |
| CLSEEDSQEYRYLCF | 541 | Q5T1H1 | |
| LDEENCVYRTDGYNC | 976 | Q5T1H1 | |
| LIECTDTFCTYDDYN | 331 | Q10469 | |
| YNREECLRTVECYNP | 376 | Q9Y6Y0 | |
| ERCSHENIISYAAYC | 221 | Q96KR4 | |
| CRSYEEIVQLCDDYD | 91 | Q8TDN1 | |
| LRNIYDDSSIYQCCE | 3486 | Q5CZC0 | |
| CSNYYNFLRCTEPED | 311 | Q9H3G5 | |
| TNCVCRNGYYRADLD | 301 | P29323 | |
| LEISPDCSQYDRVYC | 151 | Q9NV79 | |
| DHYYVEQSTQTCERC | 1606 | Q92824 | |
| AALQDYELQADTYRC | 816 | Q92817 | |
| ACSISEARYLYDQLA | 256 | P48506 | |
| YETIRNIDCYSTDFC | 296 | Q96N66 | |
| SCELNPERCQYYSVS | 446 | P27487 | |
| CLRLDKSCQHNYYED | 696 | Q6UVM3 | |
| YLASLSEYDQCLEEN | 231 | P30679 | |
| CREYEIQYLTCPNDQ | 51 | Q30KQ4 | |
| CEGYNYQVDELSCEL | 541 | O00222 | |
| QQNVYTCLDSDACYE | 1106 | A2RRP1 | |
| QYRCIECNQEAKELY | 31 | Q9H2C2 | |
| YLSNRCCILYVTEAD | 51 | Q9BTP7 | |
| ADKENCSAYYERCLQ | 186 | Q86VU5 | |
| SYCYCQEVLDRLIQC | 611 | Q6NUI2 | |
| ACYERSNEYQLIDCA | 161 | P63092 | |
| YYHTQRLECIDNDEC | 1286 | Q8N2S1 | |
| LDRQATYTECCCLYG | 1366 | Q8N2S1 | |
| CLDIDECRYGYCQQL | 166 | Q9UBX5 | |
| ADLYRNCETDTLINY | 836 | P53992 | |
| YNCDETANLYHCLID | 3071 | Q9NZJ4 | |
| TCHNSIYEQSCEVYR | 581 | Q8WYK1 | |
| QECYYQDDLRVLSSL | 271 | Q15542 | |
| RYCYCLNNRTNDLSD | 136 | C9JL84 | |
| YLQSQCDCCSYRLDP | 5096 | A2VEC9 | |
| LTDGYACEVRCQNIY | 236 | O15226 | |
| ENRILLYACRNCDYQ | 31 | P36954 | |
| LYACRNCDYQQEADN | 36 | P36954 | |
| CQAYELADYSNLRET | 556 | P25100 | |
| FDIQRCYCNYTTDVV | 176 | P24557 | |
| DLTLRCDYYGCNQTA | 321 | Q9H3R2 | |
| AFLADEYCNYCRDIL | 176 | Q6ZV50 | |
| EYCNYCRDILRNVED | 181 | Q6ZV50 | |
| AENRYYCESCASLQD | 776 | Q9P2H5 | |
| YVCSECNQLYGSLEE | 16 | Q6ZN55 | |
| TLCECYDELGNRYQL | 101 | Q9HAC8 | |
| CNSLDYNLRVYCVDN | 701 | Q6UXZ4 | |
| SNTETLCSEQKYYCE | 216 | P62068 | |
| NCSQDLDEGYYICRA | 376 | Q8N0Z9 | |
| CDVPLYDICDYNVSR | 21 | Q8N6K0 | |
| YDICDYNVSRDRCQE | 26 | Q8N6K0 | |
| QCEYCLQYFSRTDRV | 256 | Q9UQR1 | |
| EYCEVYQTPVQDTRC | 326 | Q658N2 | |
| NPLDICYDVLCENAY | 961 | Q9BZH6 | |
| TLVRICDECNYGSYQ | 41 | Q7RTV0 | |
| ALDTNYCFRNLEENC | 301 | P10600 | |
| SDYRLLCDINKYVCN | 996 | Q7Z3T8 | |
| ICSDCYDNANIYSRT | 901 | O94898 |